Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
7 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
lenvatinib
×
Gastrointestinal
×
Clear all
Filters
3
NCT05319730
2026-03-02
MK-3475-06B
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
230 enrolled
NCT03713593
2026-02-05
LEAP-002
Merck Sharp & Dohme LLC
Phase 3
Completed
794 enrolled
30 charts
NCT04776148
2026-02-05
MK-7902-017
Merck Sharp & Dohme LLC
Phase 3
Completed
563 enrolled
32 charts
NCT04246177
2025-12-17
LEAP-012
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
480 enrolled
NCT04949256
2025-12-15
MK-7902-014
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
864 enrolled
NCT03797326
2025-11-17
LEAP-005
Merck Sharp & Dohme LLC
Phase 2
Completed
611 enrolled
27 charts
NCT05007106
2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2
Completed
613 enrolled